Narayan Prabhu
2023
In 2023, Narayan Prabhu earned a total compensation of $1.2M as Chief Financial Officer at REVIVA PHARMACEUTICALS HOLDINGS, a 203% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $95,940 |
|---|---|
| Option Awards | $827,838 |
| Salary | $325,000 |
| Total | $1,248,778 |
Prabhu received $827.8K in option awards, accounting for 66% of the total pay in 2023.
Prabhu also received $95.9K in non-equity incentive plan and $325K in salary.
Rankings
In 2023, Narayan Prabhu's compensation ranked 960th out of 2,907 executives tracked by ExecPay. In other words, Prabhu earned more than 67.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 960 out of 2,907 | 67th |
Division Manufacturing | 572 out of 1,599 | 64th |
Major group Chemicals And Allied Products | 391 out of 901 | 57th |
Industry group Drugs | 380 out of 864 | 56th |
Industry Pharmaceutical Preparations | 258 out of 622 | 59th |
Source: SEC filing on October 28, 2024.
Prabhu's colleagues
We found one more compensation record of an executive who worked with Narayan Prabhu at REVIVA PHARMACEUTICALS HOLDINGS in 2023.
2023
Laxminarayan Bhat
REVIVA PHARMACEUTICALS HOLDINGS